Efficacy and Safety of Morning Versus Evening Intake of Simvast Controlled Release (CR) Tablet in Patients With Hyperlipidemia
Clinical trial NCT00973115 · COMPLETED
Trial details
- NCT number
- NCT00973115
- Sponsor
- Hanmi Pharmaceutical Company Limited
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2007-11-01
- Primary completion
- 2009-08-01
- Enrollment
- 132
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.